Stocks · Health care · Biological Products, (No Diagnostic Substances)

Aura Biosciences, Inc.

AURA Clue Score20
United States Fiscal year ends December CIK 0001501796 Results filed 11 Aug 2026

What the insiders did No buying or selling

By person

16 insiders · 0 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Natalie C. Holles
See Remarks
—
—
—
1,153,962
$7.41M
—
los Pinos Elisabet de
See Remarks
—
—
—
575,815
$3.70M
+77.6%
Janet Jill Hopkins
Chief Medical Officer
—
—
—
380,190
$2.44M
+132.5%
Anthony S Gibney
See Remarks
—
—
—
265,354
$1.70M
+3,040%
Mark Plavsic
Chief Technology Officer
—
—
—
243,736
$1.56M
+101.2%
Conor Kilroy
See Remarks
—
—
—
232,693
$1.49M
+142.4%
David Michael Johnson
Director
—
—
—
194,167
$1.25M
+32.8%
Amy Elazzouzi
SVP, Finance & PAO
—
—
—
143,600
$921.91K
+264.1%
Susan Abu-Absi
Chief Operating Officer
—
—
—
134,513
$863.57K
—
Julie Person
Chief People Officer
—
—
—
107,611
$690.86K
—
Erica Kratz
Chief Reg. & Quality Officer
—
—
—
100,885
$647.68K
—
Sapna Srivastava
Director
—
—
—
38,500
$247.17K
+266.7%
Antony C. Mattessich
Director
—
—
—
38,500
$247.17K
+266.7%
Teresa Marie Bitetti
Director
—
—
—
36,000
$231.12K
—
Jeremy Bender
Director
—
—
—
30,000
$192.60K
—
Matrix Capital Management Company, LP entity
10% owner
—
—
—
0
$0.00
−100.0%

No percentages here. This company's share count has moved by a factor of 2.1 over the window, from 50,225,312 to 103,704,809 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.